CANCER AND LEUKEMIA GROUP B

这是一份继续研究临床癌症的申请， CALGB的成员。 纽约医院-康奈尔医疗中心 及其相关机构，北岸大学医院和 纪念医院的凡士通放射中心，仍然是一个主要的 科学、临床和行政活动的贡献者 CALGB 这些都体现在我们对科学事务的参与上 和CALGB的程序。 领导活动反映在我们的 对CALGB的行政和科学贡献，以及我们的试点和 第二阶段计划和我们的出版物。 我们的目标是在设计中采取合作的方式， 进行癌症治疗试验。 在这方面，我们将（1） 确定缓解和其他反应的效果、程度和持续时间 治疗目前关注的疾病CALGB，（2）研究 疾病的自然史和一些生物制剂 通过各种实验治疗方法修改的CALGB进行研究 方案，（3）促进这些疾病的最佳治疗，（4） 参与CALGB的试验性II期和多学科试验，（5） 继续保持高水平的患者增加，并继续改善数据 收集，（6）继续积极参与集团活动， 它属于群体科学和群体管理， 2005年12月25日至26日期间， 两年

This is an application for continuing research in clinical cancer as a member of CALGB. The New York Hospital-Cornell Medical Center together with its associated institutions, North Shore University Hospital and the Firestone Radiation Center at Memorial Hospital, remains a major contributor to the scientific, clinical and administrative activities of CALGB. These are reflected in our participation in the scientific affairs and programs of CALGB. Leadership activities are reflected in our administrative and scientific contributions to CALGB, and in our pilot and phase II programs and in our publications. Our aims are to participate in a cooperative approach in the design and conduct of therapeutic trials in cancer. In this context, we will (1) determine the effect, extent and duration of remission and other responses to treatment of the diseases currently of concern to CALGB, (2) study the natural history and some of the biologic agents of the diseases investigated by CALGB as modified by various experimental therapeutic regimens, (3) promote the best possible treatment of these disorders, (4) participate in pilot phase II and multidisciplinary trials of CALGB, (5) continue a high level of patient accrual and continue to improve data collection, (6) continue our vigorous participation in Group activities as it pertains to Group science and Group administration with particular reference to change in the Group's orientation and resources in the last two years.